FBIO
Price:
$1.77
Market Cap:
$40.38M
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules for severe recalcitrant nodular acne. It also develops late stage product candidates, such as intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for the treatment of Menkes disease; MB-107 and MB-207 for the ...[Read more]
Industry
Biotechnology
IPO Date
2011-11-17
Stock Exchange
NASDAQ
Ticker
FBIO
According to Fortress Biotech, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.06. This represents a change of -93.24% compared to the average of -0.89 of the last 4 quarters.
The mean historical PE Ratio of Fortress Biotech, Inc. over the last ten years is -1.83. The current -0.06 PE Ratio has changed 227.20% with respect to the historical average. Over the past ten years (40 quarters), FBIO's PE Ratio was at its highest in in the March 2019 quarter at 21.63. The PE Ratio was at its lowest in in the June 2021 quarter at -20.44.
Average
-1.83
Median
-2.09
Minimum
-4.35
Maximum
-0.27
Discovering the peaks and valleys of Fortress Biotech, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 511.00%
Maximum Annual PE Ratio = -0.27
Minimum Annual Increase = -82.13%
Minimum Annual PE Ratio = -4.35
Year | PE Ratio | Change |
---|---|---|
2023 | -0.40 | 46.83% |
2022 | -0.27 | -77.87% |
2021 | -1.24 | -44.09% |
2020 | -2.22 | -18.33% |
2019 | -2.71 | 511.00% |
2018 | -0.44 | -82.13% |
2017 | -2.49 | 26.91% |
2016 | -1.96 | -13.16% |
2015 | -2.26 | -48.13% |
2014 | -4.35 | 101.86% |
The current PE Ratio of Fortress Biotech, Inc. (FBIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.64
5-year avg
-1.37
10-year avg
-1.83
Fortress Biotech, Inc.’s PE Ratio is greater than Mustang Bio, Inc. (-0.20), greater than Achilles Therapeutics plc (-0.45), greater than Aptose Biosciences Inc. (-0.15), greater than Fortress Biotech, Inc. (-0.71), greater than Checkpoint Therapeutics, Inc. (-1.81), greater than Avenue Therapeutics, Inc. (-0.31), greater than Pieris Pharmaceuticals, Inc. (-0.93), greater than Aileron Therapeutics, Inc. (-2.21), greater than Reviva Pharmaceuticals Holdings, Inc. (-1.10), greater than Eyenovia, Inc. (-0.70), greater than Cognition Therapeutics, Inc. (-0.73), greater than TransCode Therapeutics, Inc. (-0.10), greater than Kodiak Sciences Inc. (-0.61), greater than XOMA Corporation (-17.42), greater than ZIVO Bioscience, Inc. (-2.46), greater than Lumos Pharma, Inc. (-0.86), greater than Reviva Pharmaceuticals Holdings, Inc. (-1.10), greater than Athira Pharma, Inc. (-0.18), less than ACADIA Pharmaceuticals Inc. (87.04), greater than Cabaletta Bio, Inc. (-2.34),
Company | PE Ratio | Market cap |
---|---|---|
-0.20 | $10.22M | |
-0.45 | $29.58M | |
-0.15 | $6.57M | |
-0.71 | $44.00M | |
-1.81 | $93.07M | |
-0.31 | $4.05M | |
-0.93 | $22.50M | |
-2.21 | $60.66M | |
-1.10 | $42.03M | |
-0.70 | $37.99M | |
-0.73 | $22.87M | |
-0.10 | $4.56M | |
-0.61 | $121.54M | |
-17.42 | $332.97M | |
-2.46 | $37.03M | |
-0.86 | $30.87M | |
-1.10 | $44.68M | |
-0.18 | $20.81M | |
87.04 | $2.67B | |
-2.34 | $208.10M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fortress Biotech, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Fortress Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Fortress Biotech, Inc.'s PE Ratio?
How is the PE Ratio calculated for Fortress Biotech, Inc. (FBIO)?
What is the highest PE Ratio for Fortress Biotech, Inc. (FBIO)?
What is the 3-year average PE Ratio for Fortress Biotech, Inc. (FBIO)?
What is the 5-year average PE Ratio for Fortress Biotech, Inc. (FBIO)?
How does the current PE Ratio for Fortress Biotech, Inc. (FBIO) compare to its historical average?